Literature DB >> 15190315

Global fund changes tack on malaria therapy.

Declan Butler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15190315     DOI： 10.1038/429588a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  5 in total

1.  Fighting malaria at the crossroads.

Authors:  Andrea Rinaldi
Journal:  EMBO Rep       Date:  2004-09       Impact factor: 8.807

2.  Assessment of in vivo antimalarial activity of rifampicin, isoniazide, and ethambutol combination therapy.

Authors:  Nayak P Aditya; Swati Patankar; Basavaraj Madhusudhan
Journal:  Parasitol Res       Date:  2010-02-18       Impact factor: 2.289

3.  Time for a "Third Wave" of malaria activism to tackle the drug stock-out crisis.

Authors: 
Journal:  PLoS Med       Date:  2009-11-24       Impact factor: 11.069

4.  In vitro study of parasite elimination and endothelial protection by curcumin: adjunctive therapy for cerebral malaria.

Authors:  Sarun Kunwittaya; Lertyot Treeratanapiboon; Apapan Srisarin; Chartchalerm Isarankura-Na-Ayudhya; Virapong Prachayasittikul
Journal:  EXCLI J       Date:  2014-03-20       Impact factor: 4.068

5.  Production and characterization of specific monoclonal antibodies binding the Plasmodium falciparum diagnostic biomarker, histidine-rich protein 2.

Authors:  Chiuan Herng Leow; Martina Jones; Qin Cheng; Stephen Mahler; James McCarthy
Journal:  Malar J       Date:  2014-07-18       Impact factor: 2.979
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.